Cartesian Therapeutics, Inc.
← Back to RNAC Overview

Cartesian Therapeutics, Inc. (RNAC)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-0.51

Financial Fundamentals

RNAC • Quarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2015-03-31-6.55
2015-06-30-5.47
2015-09-30-6.56
2015-12-31—
2016-03-31-6.60
2016-06-30-1.40
2016-09-30-6.96
2016-12-31-4.63
2017-03-31-3.64
2017-06-30-4.88
2017-09-30-5.72
2017-12-31-2.43
2018-03-31-2.99
2018-06-30-3.28
2018-09-30-4.65
2018-12-31-0.85
2019-03-31-1.68
2019-06-30-1.00
2019-09-30-1.41
2019-12-31-1.74
2020-03-31-2.42
2020-06-30-2.38
2020-09-30-5.59
2020-12-31-4.41
2021-03-31-4.24
2021-06-3021.66
2021-09-30-6.69
2021-12-317.67
2022-03-311.33
2022-06-305.65
2022-09-30-7.94
2022-12-316.94
2023-03-31-2.46
2023-06-30-3.77
2023-09-30-4.56
2023-12-31-0.14
2024-03-31-0.40
2024-06-307.33
2024-09-30-3.58
2024-12-31-11.31
2025-03-31-4.82
2025-06-304.25
2025-09-30-1.85
2025-12-31-0.51

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.